Abstract
Eight weeks of treatment with extended‐release methylphenidate did not significantly improve symptoms of attention‐deficit hyperactivity disorder (ADHD) relative to placebo in a group of young prison inmates, a new study has found. Participants receiving methylphenidate also did not experience significant improvement compared with placebo on secondary measures of psychopathology and emotional dysregulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
